Related by context. Frequent words. (Click for all words.) 72 Sangamo ZFP technology 70 based pretargeting methods 70 oncolytic virus therapies 70 BiTE R 70 unique PER.C6 ® 67 Nanobody 67 staphylococcal vaccines 66 include bioavailability enhancement 66 MKC# MT 66 optical biosensors 66 MVA BN R 66 addressing idiopathic pulmonary 65 drug conjugate 65 includes investigational compounds 65 fibrosis IPF 64 activity dependent neuroprotective 64 Thiarabine 64 immatics 64 drug conjugate ADC 64 malignant infectious 64 mediate RNAi 64 TLR9 agonist 64 ZFP Therapeutics 64 Antigen Express comprise immunotherapeutics 63 ® bortezomib 63 drug conjugates 63 MassARRAY R 63 PLK1 SNALP 63 ALN PCS 63 Initiates Phase II 63 candidate ridaforolimus 63 AeroLEF R 63 topical anti infective 63 stable nucleic acid 63 Auxilium transmucosal film 62 novel anti infective 62 liposomal formulation 62 proteasome inhibitor 62 boron chemistry 62 MKC# 62 targeted immunotherapies 62 Completes Patient Enrollment 62 GVAX R 62 approvals revisions mgmt 62 humanized antibody 62 nitric oxide donating 62 Allovectin 7 R 62 R sorafenib tablets 62 PER.C6 ® 62 overactive bladder AA# 62 Ligand proprietary 62 BiovaxID TM 62 epothilones 62 XL# XL# XL# XL# 62 novel antibody therapeutics 61 Medarex applies 61 polyclonal antibody 61 Lipid Polymer Micelle LPM 61 PNP inhibitor 61 Medarex logo 61 New Chemical Entities 61 includes iFinix RealTime 61 Syncria 61 personalized immunotherapy 61 chemogenomics 61 concerning CombinatoRx 61 oncolytic 61 active cellular immunotherapy 61 leading lipid nanoparticle 61 anti CD# monoclonal 61 therapeutic monoclonal antibodies 61 Inc. Nasdaq NEXM 61 siRNA therapeutic 61 R bortezomib 61 immunotherapeutics 61 oncolytic viruses 61 DNA plasmids 61 HepeX B 61 Epitomics 61 Factor VIIa 61 proprietary nanopolymer delivery 61 LEX System 61 Dyax logo 61 protein ADNP 61 HuCAL 60 Idera Pharmaceuticals 60 adenovector 60 cancer immunotherapies 60 Idera Pharmaceuticals develops 60 Allovectin 7 60 targeting CD# 60 Daclizumab 60 Atom bearing MIDs 60 GRNVAC1 60 novel RNAi therapeutics 60 Onalta 60 synthetic peptide 60 Panzem R 60 Amgen discovers develops 60 Mersana 60 XOMA proprietary